Cell Therapy News/Articles, page-16799

My wish for our type A meeting ...

I am still supremely confident that Mesoblast will eventually start getting ticks & approvals from the fda...

my hope for this meeting is that whilst

1. providing the extra data which proves the stock of remestemcel-L for commercialisation is the the same or very similar to the cells that were provided in our recent trials..

2. we go into this meeting with a back up , with adults trials ready to go ( in short course )

I hope that our trials begin very soon , because wether we can or cannot prove/ convince the fda with the new potency data presented that we deserve an Accelerated Approval ... then at least we are already moving forward towards a rapid outcome from a short trial to finally get us Full Approval ...

mesoblast deserves a break and the kids and adults with SR aGVHD deserve a break we the long term holders deserve a break...

It gives me great confidence that the CEO , CMO and board of directors have all agreed to substantial cuts to their fees and instead they will be receiving Long Term Incentives ... I like this!!!